Laura K. Aguilar's most recent trade in Candel Therapeutics Inc was a trade of 171,335 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on May 6, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. | 06 May 2022 | 171,335 | 1,102,374 | - | 1.5 | 250,149 | Common Stock |
| Candel Therapeutics Inc | Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 76,717 | 0 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 76,717 | 0 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Laura K. Aguilar | Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.65 per share. | 06 May 2022 | 68,534 | 1,033,840 | - | 3.6 | 250,149 | Common Stock |
| Candel Therapeutics Inc | Laura K. Aguilar | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 17,901 | 0 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Laura K. Aguilar | Chief Medical Officer | 29 Jul 2021 | 137,881 | 0 | - | - | Series B Preferred Stock | ||
| Candel Therapeutics Inc | Laura K. Aguilar | Chief Medical Officer | 29 Jul 2021 | 56,096 | 931,039 | - | - | Common Stock |